Market Overview

Bank of America Maintains Neutral on The Medicines Company, Raises PO to $28.00

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for MDCO

DateFirmActionFromTo
Oct 2014Credit SuisseMaintainsNeutral
Apr 2014Leerink SwannDowngradesOutperformMarket Perform
Apr 2014Piper JaffrayDowngradesOverweightNeutral

View More Analyst Ratings for MDCO
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (MDCO)

Around the Web, We're Loving...

Get Benzinga's Newsletters